-
-
-
-
-
-
-
EyePoint Pharmaceuticals Secures Pass-through Payment Status and Assignment of C-Code for DEXYCU™
-
-
-
-
-
-
-
EyePoint Pharmaceuticals Appoints David Price as Chief Financial Officer
-
-
-
-
-
-
-
EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results
-
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

